摘要
Background: Autophagy, a cellular process involving lysosomal self-digestion, plays a crucial role in recycling biomolecules and degrading dysfunctional proteins and damaged organelles. However, in non-small cell lung cancer (NSCLC), cancer cells can exploit autophagy to survive metabolic stress and develop resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which reduce treatment efficacies. Currently, most studies have found that late-stage autophagy inhibitors can hinder EGFR-TKIs resistance, while research on early-stage autophagy inhibitors is still limited. Purpose: This study investigates the mechanism via which the Xie-Bai-San (XBS) formula enhances NSCLC cell sensitivity to gefitinib, revealing the relationship between XBS-induced cell death and the inhibition of autophagosome formation. Methods: Cell viability was assessed using CCK-8 and EdU assays, lentivirus transfection was utilized to generate PC9 cells harboring the PIK3CA E545K mutation (referred to as PC9-M), autophagic flux was monitored using mCherry-GFP-LC3 adenovirus. Protein expression and colocalization were observed through immunofluorescence staining. The interaction between Bcl-2 and Beclin-1 in PC9-GR and PC9-M cells was determined via coimmunoprecipitation (Co-IP) assay, cell apoptosis was assessed by flow cytometry and PI staining, and overall survival analysis of lung adenocarcinoma patients was conducted using the TCGA database. In vivo experiments included a patient-derived xenograft (PDX) model with EGFR and PIK3CA mutations and subcutaneous mice xenografts of NSCLC cell lines (PC9 and PC9-GR). In addition, autophagic vesicles in mouse tumor tissues were observed via transmission electron microscopy analysis. Results: XBS effectively inhibits the proliferation of gefitinib-resistant NSCLC cells and induces apoptosis both in vitro and in vivo. Mechanistically, XBS suppresses gefitinib-induced autophagic flux by inhibiting autophagy through the upregulation of p-mTOR and Bcl-2 and downregulation of Beclin-1. Additionally, XBS enhances the interaction between Bcl-2 and Beclin-1, and the overexpression of Beclin-1 promotes NSCLC cell proliferation and counteracts XBS-induced cell death, while XBS demonstrates minimal impact on autophagosome-lysosome fusion or lysosome function. Conclusion: This study reveals a novel role for the XBS formula in impeding autophagy initiation and demonstrates its potential as a candidate drug to counteract autophagy-induced treatment resistance in NSCLC.
学科与关键词
- Identification of Fangjihuangqi Decoction as a late-stage autophagy inhibitor with an adjuvant anti-tumor effect against non-small cell lung cancerChen, Qiugu; Liao, Yuan; Liu, Yujiao; Song, Yue; Jiang, Junbo; Zhang, Zhen; Li, Anqi; Zheng, Mengyi; Chen, Xiaoyi; Zhao, Tingxiu; Gu, Jiangyong; Tan, Yuhui; Liu, Xiaoyi; Jiang, Yanjun; Wang, Kun; Yi, Hua*; Xiao, Jianyong*; Hu, Shan*Chinese Medicine, 2023, 18(1): 68.
- BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cellsYu, Yaya; Xiao, Zhenzhen; Lei, Chenjing; Ma, Changju; Ding, Lina; Tang, Qing; He, Yihan; Chen, Yadong; Chang, Xuesong; Zhu, Yanjuan*; Zhang, Haibo*BMC CANCER, 2023, 23(1): 732.
- Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathwayYang, Cai-Zhi; Guo, Wei; Wang, Yi-Fan; Hu, Lei-Hao; Wang, Jing; Luo, Jia-Min; Yao, Xiao-Hui; Liu, Shan; Tao, Lan-Ting; Sun, Ling-Ling*; Lin, Li-Zhu*Journal of Ethnopharmacology, 2023, 314: 116566.被引 2
